Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

3.86
+0.07001.85%
Post-market: 3.860.00000.00%19:59 EST
Volume:19.05M
Turnover:72.66M
Market Cap:1.59B
PE:-3.53
High:3.91
Open:3.79
Low:3.65
Close:3.79
52wk High:4.57
52wk Low:1.64
Shares:411.96M
Float Shares:339.00M
Volume Ratio:0.60
T/O Rate:5.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0941
EPS(LYR):-1.0941
ROE:-55.50%
ROA:-27.30%
PB:2.28
PE(LYR):-3.53

Loading ...

Feb 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]